This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Interactions and contraindications

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • organic nitrates interact with sildenafil to cause severe hypotension - concurrent use of sildenafil with nitric oxide donors or nitrites is contraindicated
  • other contraindications include hypotension (blood pressure below 90/50 mmHg), severe hepatic impairment, hereditary degenerative retinal disorders such as retinitis pigmentosa, recent stroke or myocardial infarction.
  • sildenafil should be used with caution in patients with a condition predisposing to priapism e.g. sickle cell anaemia, multiple myeloma, or leukaemia; in any patient with a penile deformity (e.g. Peyronie's disease); in those patients with active peptic ulcer disease or a bleeding disorder.
  • sildenafil is metabolised mainly by the cytochrome P450 system - the plasma levels of sildenafil are increased if there is concurrent use of another drug that is a cytochrome P450 inhibitor e.g. cimetidine. The manufacturer recommends that a starting dose dose of sildenafil 25mg should be considered if concurrently using a drug that is metabolised by the cytochrome P450 system.
  • there is no data, at present, for the use of sildenafil in males under 18 years of age, or women, and therefore sildenafil is at present contraindicated for these groups

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.